The CARBALIVE Consortium announces positive results of a Phase 2 equivalent trial of engineered macroporous carbons as a novel treatment for cirrhosis. carbalive.eu

EU Commissioner for Research, Science and Innovation mentions CARBALIVE: elpa.eu/news/jun-2017/…
NASH-NAFLD Summit-31st May 2017

CARBALIVE project featured in The Sunday Times - thetimes.co.uk/article/tiny-b…